JP2024517801A - エテルカルセチド製剤 - Google Patents

エテルカルセチド製剤 Download PDF

Info

Publication number
JP2024517801A
JP2024517801A JP2023567187A JP2023567187A JP2024517801A JP 2024517801 A JP2024517801 A JP 2024517801A JP 2023567187 A JP2023567187 A JP 2023567187A JP 2023567187 A JP2023567187 A JP 2023567187A JP 2024517801 A JP2024517801 A JP 2024517801A
Authority
JP
Japan
Prior art keywords
formulation
etelcalcetide
polysorbate
surfactant
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023567187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517801A5 (https=
Inventor
ライ，デイビッド
ミルザイ・カカーキ，イマン
Original Assignee
アムジエン・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アムジエン・インコーポレーテツド filed Critical アムジエン・インコーポレーテツド
Publication of JP2024517801A publication Critical patent/JP2024517801A/ja
Publication of JP2024517801A5 publication Critical patent/JP2024517801A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP2023567187A 2021-05-06 2022-05-03 エテルカルセチド製剤 Pending JP2024517801A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184924P 2021-05-06 2021-05-06
US63/184,924 2021-05-06
PCT/US2022/027451 WO2022235654A1 (en) 2021-05-06 2022-05-03 Etelcalcetide formulations

Publications (2)

Publication Number Publication Date
JP2024517801A true JP2024517801A (ja) 2024-04-23
JP2024517801A5 JP2024517801A5 (https=) 2025-05-12

Family

ID=81750502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023567187A Pending JP2024517801A (ja) 2021-05-06 2022-05-03 エテルカルセチド製剤

Country Status (7)

Country Link
US (1) US20240207354A1 (https=)
EP (1) EP4333805A1 (https=)
JP (1) JP2024517801A (https=)
AU (1) AU2022268916A1 (https=)
CA (1) CA3218559A1 (https=)
MX (1) MX2023013066A (https=)
WO (1) WO2022235654A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
MX2012000100A (es) * 2009-07-01 2012-04-02 Fresenius Med Care Hldg Inc Dispositivos de suministro de farmaco y sistemas y metodos relacionados.
MA38724B1 (fr) 2013-06-28 2017-11-30 Amgen Inc Formulation liquide stable d'amg 416 (velcalcétide)
WO2021080822A1 (en) * 2019-10-24 2021-04-29 Amgen Inc. Systems and methods for drug delivery

Also Published As

Publication number Publication date
WO2022235654A1 (en) 2022-11-10
US20240207354A1 (en) 2024-06-27
MX2023013066A (es) 2023-11-15
CA3218559A1 (en) 2022-11-10
AU2022268916A1 (en) 2023-11-09
EP4333805A1 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
US20230124105A1 (en) Pharmaceutical composition
AU2003267131B2 (en) Formulation for lipophilic agents
JP2012096063A (ja) 医薬容器内の安定化した液体タンパク質の処方物
TW201717997A (zh) 速效胰島素組合物
TW201542239A (zh) 穩定液體調配物
JP2023123742A (ja) 保存製剤
CN102958519B (zh) 包含扑热息痛的药物组合物及其制备方法
JP2024517801A (ja) エテルカルセチド製剤
JP6445169B2 (ja) α型インターフェロンを含有する安定したベンジルアルコールフリーの水溶液製剤
US20240139278A1 (en) Oxytocin formulation
CN103656616B (zh) 巴替非班注射剂及其制备
KR20190087039A (ko) 리세드론산 또는 그의 염 및 비타민d를 함유하는 경구용 에멀젼 조성물 및 그 제조방법
EA053198B1 (ru) Улучшенный лиофилизированный состав
HK1244442A1 (en) Pharmaceutical composition
AU2013204097A1 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250430

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250430